Literature DB >> 3510950

Expression of beta 2-microglobulin on hepatocytes in acute and chronic type B hepatitis.

Y Nagafuchi, P J Scheuer.   

Abstract

beta 2-Microglobulin display was examined in 131 liver biopsies from patients with acute and chronic type B hepatitis, using an indirect immunoperoxidase method. Enhanced expression of beta 2-microglobulin on hepatocyte membranes was observed in patients with acute hepatitis, chronic active hepatitis with moderate to severe activity and cirrhosis, when compared with normal liver. In acute hepatitis, beta 2-microglobulin-positive hepatocytes were mainly observed in perivenular areas in association with bridging necrosis. In chronic hepatitis, beta 2-microglobulin-positive hepatocytes were observed mainly in periportal zones and in some areas of lobular activity. Diffuse-enhanced display of beta 2-microglobulin on hepatocytes was observed in 5 of 6 patients treated with lymphoblastoid interferon as part of a trial of antiviral therapy. The mechanism by which beta 2-microglobulin display is enhanced on hepatocytes in patients not treated with interferon is uncertain. However, display of beta 2-microglobulin on hepatocytes probably reflects display of HLA-A, B and C antigens and may influence the course of hepatitis B virus infection by increasing susceptibility of the affected cells to T cell-mediated immune attack.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510950     DOI: 10.1002/hep.1840060105

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.

Authors:  G Ballardini; F B Bianchi; R Mirakian; M Fallani; E Pisi; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

2.  Immunolocalization of alpha interferon in liver disease.

Authors:  C G Sutherland; A M al-Badri; A G Howatson; M A Farquharson; A K Foulis
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

3.  Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma.

Authors:  C H Sung; C P Hu; H C Hsu; A K Ng; C K Chou; L P Ting; T S Su; S H Han; C M Chang
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  Serum beta2-microglobulin in chronic hepatitis C.

Authors:  M Malaguarnera; S Restuccia; I Di Fazio; A M Zoccolo; B A Trovato; G Pistone
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

5.  Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.

Authors:  R Wejstål; G Norkrans; O Weiland; R Schvarcz; D Fuchs; H Wachter; A Fryden; H Glaumann
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

6.  Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology.

Authors:  J Y Lau; G L Bird; N V Naoumov; R Williams
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

7.  Expression rate of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B.

Authors:  R Fukuda; S Satoh; X T Nguyen; Y Uchida; N Kohge; S Akagi; S Ikeda; M Watanabe; S Fukumoto
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

8.  Class I and class II major histocompatibility complex antigens on hepatocytes: importance of the method of detection and expression in histologically normal and diseased livers.

Authors:  G Senaldi; A Lobo-Yeo; A P Mowat; G Mieli-Vergani; D Vergani
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

9.  HLA expression in human hepatocellular carcinoma.

Authors:  A C Paterson; R Sciot; M C Kew; F Callea; G M Dusheiko; V J Desmet
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.